| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109-0589; and 2 Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, North Carolina 27599
Insulin-like growth factor (IGF)-I and its binding protein IGF binding protein 5 (IGFBP-5) were highly expressed in inflamed and fibrotic intestine in experimental Crohn's disease. IGF-I induced proliferation and increased collagen synthesis by smooth muscle cells and fibroblasts/myofibroblasts in vitro. Here we studied IGF-I and IGFBP-5 in Crohn's disease tissue. Tissue was collected from patients undergoing intestinal resection for Crohn's disease. IGF-I and IGFBP-5 mRNAs were quantitated by RNase protection assay and Northern blot analysis, respectively. In situ hybridization was performed to localize mRNA expression, and Western immunoblot was performed to quantitate protein expression. IGF-I and IGFBP-5 mRNAs were increased in inflamed/fibrotic intestine compared with normal-appearing intestine. IGF-I mRNA was expressed in multiple cell types in the lamina propria and fibroblast-like cells of the submucosa and muscularis externa. IGFBP-5 mRNA was highly expressed in smooth muscle of the muscularis mucosae and muscularis externa as well as fibroblast-like cells throughout the bowel wall. Tissue IGFBP-5 protein correlated with collagen type I (r = 0.82). These findings are consistent with a mechanism whereby IGF-I acts on smooth muscle and fibroblasts/myofibroblasts to increase collagen synthesis and cellular proliferation; its effects may be modulated by locally expressed IGFBP-5.
inflammatory bowel disease; fibrosis; smooth muscle cells; inflammation
This article has been cited by other articles:
|
|
 |
|
  T. A. Markel, P. R. Crisostomo, M. Wang, C. M. Herring, and D. R. Meldrum Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G657 - G662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Kuemmerle Occupation of {alpha}vbeta3-integrin by endogenous ligands modulates IGF-I receptor activation and proliferation of human intestinal smooth muscle Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1194 - G1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Kuemmerle Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3{beta} activity Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G101 - G110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Kuemmerle, K. S. Murthy, and J. G. Bowers IGFBP-3 activates TGF-{beta} receptors and directly inhibits growth in human intestinal smooth muscle cells Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G795 - G802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Xin, Y. T. Hou, L. Li, P. Schmiedlin-Ren, G. M. Christman, H.-L. Cheng, K. N. Bitar, and E. M. Zimmermann IGF-I increases IGFBP-5 and collagen {alpha}1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G777 - G783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Kuemmerle, H. Zhou, and J. G. Bowers IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G412 - G419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Howarth Insulin-Like Growth Factor-I and the Gastrointestinal System: Therapeutic Indications and Safety Implications J. Nutr., July 1, 2003; 133(7): 2109 - 2112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Kuemmerle IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase Am J Physiol Gastrointest Liver Physiol, March 1, 2003; 284(3): G411 - G422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Solomon, M. Grueterich, D.-Q. Li, D. Meller, S.-B. Lee, and S. C. G. Tseng Overexpression of Insulin-like Growth Factor-Binding Protein-2 in Pterygium Body Fibroblasts Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Williams, C. R. Fuller, J. Fagin, and P. K. Lund Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G875 - G885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Simmons, J. B. Pucilowska, T. O. Keku, and P. K. Lund IGF-I and TGF-beta 1 have distinct effects on phenotype and proliferation of intestinal fibroblasts Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G809 - G818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Saban, N.-B. Nguyen, T. G. Hammond, and R. Saban Gene Expression Profiling of Mouse Bladder Inflammatory Responses to LPS, Substance P, and Antigen-Stimulation Am. J. Pathol., June 1, 2002; 160(6): 2095 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Gillingham, K. R. Kritsch, S. G. Murali, P. K. Lund, and D. M. Ney Resection upregulates the IGF-I system of parenterally fed rats with jejunocolic anastomosis Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1158 - G1168. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
